Format
Sort by

Send to

Choose Destination

Search results

Items: 12

1.

Characterization of HIV drug resistance mutations among patients failing first-line antiretroviral therapy from a tertiary referral center in Lusaka, Zambia.

Seu L, Mulenga LB, Siwingwa M, Sikazwe I, Lambwe N, Guffey MB, Chi BH.

J Med Virol. 2015 Jul;87(7):1149-57. doi: 10.1002/jmv.24162. Epub 2015 Mar 5.

2.

Age at antiretroviral therapy initiation predicts immune recovery, death, and loss to follow-up among HIV-infected adults in urban Zambia.

Vinikoor MJ, Joseph J, Mwale J, Marx MA, Goma FM, Mulenga LB, Stringer JS, Eron JJ, Chi BH.

AIDS Res Hum Retroviruses. 2014 Oct;30(10):949-55. doi: 10.1089/AID.2014.0046. Epub 2014 Aug 5.

3.

Six-month hemoglobin concentration and its association with subsequent mortality among adults on antiretroviral therapy in Lusaka, Zambia.

Giganti MJ, Limbada M, Mwango A, Moyo C, Mulenga LB, Guffey MB, Mulenga PL, Bolton-Moore C, Stringer JS, Chi BH.

J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):120-3. doi: 10.1097/QAI.0b013e31825da11d.

4.

Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America.

Chi BH, Yiannoutsos CT, Westfall AO, Newman JE, Zhou J, Cesar C, Brinkhof MW, Mwango A, Balestre E, Carriquiry G, Sirisanthana T, Mukumbi H, Martin JN, Grimsrud A, Bacon M, Thiebaut R; International Epidemiologic Databases to Evaluate AIDS Collaboration.

PLoS Med. 2011 Oct;8(10):e1001111. doi: 10.1371/journal.pmed.1001111. Epub 2011 Oct 25.

5.

Comparative outcomes of tenofovir-based and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia.

Chi BH, Mwango A, Giganti MJ, Sikazwe I, Moyo C, Schuttner L, Mulenga LB, Bolton-Moore C, Chintu NT, Sheneberger R, Stringer EM, Stringer JS.

J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):475-81. doi: 10.1097/QAI.0b013e31823058a3.

6.

Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia.

Koethe JR, Blevins M, Nyirenda C, Kabagambe EK, Shepherd BE, Wester CW, Zulu I, Chiasera JM, Mulenga LB, Mwango A, Heimburger DC.

J Int AIDS Soc. 2011 Apr 10;14:19. doi: 10.1186/1758-2652-14-19.

7.

An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs.

Chi BH, Cantrell RA, Mwango A, Westfall AO, Mutale W, Limbada M, Mulenga LB, Vermund SH, Stringer JS.

Am J Epidemiol. 2010 Apr 15;171(8):924-31. doi: 10.1093/aje/kwq008. Epub 2010 Mar 10.

8.

Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia.

Chi BH, Mwango A, Giganti M, Mulenga LB, Tambatamba-Chapula B, Reid SE, Bolton-Moore C, Chintu N, Mulenga PL, Stringer EM, Sheneberger R, Mwaba P, Stringer JS.

J Acquir Immune Defic Syndr. 2010 May 1;54(1):63-70. doi: 10.1097/QAI.0b013e3181c6c65c.

9.

Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia.

Chi BH, Cantrell RA, Zulu I, Mulenga LB, Levy JW, Tambatamba BC, Reid S, Mwango A, Mwinga A, Bulterys M, Saag MS, Stringer JS.

Int J Epidemiol. 2009 Jun;38(3):746-56. doi: 10.1093/ije/dyp004. Epub 2009 Feb 17.

10.

Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia.

Mulenga LB, Kruse G, Lakhi S, Cantrell RA, Reid SE, Zulu I, Stringer EM, Krishnasami Z, Mwinga A, Saag MS, Stringer JS, Chi BH.

AIDS. 2008 Sep 12;22(14):1821-7. doi: 10.1097/QAD.0b013e328307a051.

11.

Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy.

Goldman JD, Cantrell RA, Mulenga LB, Tambatamba BC, Reid SE, Levy JW, Limbada M, Taylor A, Saag MS, Vermund SH, Stringer JS, Chi BH.

AIDS Res Hum Retroviruses. 2008 Aug;24(8):1031-5. doi: 10.1089/aid.2008.0035.

12.

Abandonment of antiretroviral therapy: a potential barrier to scale-up in sub-Saharan Africa.

Reid SE, Mulenga LB, Folk WR, Tambatamba BC, Chi BH.

S Afr Med J. 2008 Jun;98(6):448, 450. No abstract available.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk